Amedisys Overview
Amedisys Target Price
Analysts' 12-month price predictions for AMED.
Share Price
$94.55
Average Target Price
$100.00
5.8% upside
5.8% upside1 analysts in the last 4 months
High: $100 | Low: $100
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-25 | RBC CapitalFrank Morgan | $100 | 5.8% upside |  |
| 2023-07-06 | JefferiesBrian Tanquilut | $90.8 |  4% downside | |
| 2023-01-05 | Leerink Partners | $85 | 10.1% downside | |
| 2022-11-11 | Stephens | $106 | 12.1% upside | |
| 2022-07-26 | Truist FinancialDavid MacDonald | $150 | 58.6% upside | |
| 2022-07-03 | Deutsche BankJustin Bowers | $175 | 85.1% upside | |
| 2022-04-29 | Credit Suisse | $182 | 92.5% upside | |
| 2022-04-29 | Raymond James | $180 | 90.4% upside | |
| 2022-04-29 | Leerink Partners | $131 | 38.6% upside | |
| 2022-02-25 | BMO CapitalMatthew Borsch | $190 | 101% upside | |
| 2022-02-25 | RBC CapitalBen Hendrix | $199 | 110.5% upside | |
| 2022-02-24 | Deutsche BankJustin Bowers | $230 | 143.3% upside | |
| 2022-02-24 | Benchmark Co.Bill Sutherland | $175 | 85.1% upside | |
| 2021-11-04 | StephensScott Fidel | $185 | 95.7% upside | |